Philip J. Kuehl - Concepedia

Author

Philip J. Kuehl

Lovelace Respiratory Research Institute ORCID

Also Known As

J. Kuehl, Philip, Kuehl, P.J., Kuehl, Philip J., P J Kuehl, P KUEHL, P Kuehl, P. J. Kuehl, P. Kuehl, P.J. Kuehl, Phil J. Kuehl

114

Publications

Citations

H-Index

Concepts

All Affiliations

Lovelace Respiratory Research Institute Lovelace Medical Center United States Food and Drug Administration Biomedical Research Institute University of North Carolina at Chapel Hill

About

Philip J. Kuehl is an author at Lovelace Respiratory Research Institute specializing in medicine, pharmacology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	846
2	Allergy	7	7	216
3	Engineering	4	4	319
4	Health Sciences	3	3	135
5	Business	1	1	37

Philip J. Kuehl

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery Allen L. Feng, Mohammed A. Boraey, Morgan Gwin, International Journal of Pharmaceutics Cell-based Drug DeliveryNanomedicineLeucine Containing MicroparticlesEngineeringMedicine	2011	173
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model Stephanie N. Langel, Susan Johnson, Clarissa Martinez, Science Translational Medicine VaccinationHamster ModelMucosal RouteVaccine DevelopmentSars-cov-2 Vaccines	2022	114
Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products Stephen P. Newman, William D. Bennett, Martyn F. Biddiscombe, Journal of Aerosol Medicine and Pulmonary Drug Delivery AsthmaComputed TomographyAir QualityRegional Lung DepositionTreatment Verification	2012	109
Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD Jayne E. Hastedt, Per Bäckman, Andrew Clark, AAPS Open	2016	107
Regional particle size dependent deposition of inhaled aerosols in rats and mice Philip J. Kuehl, Tamara L. Anderson, Gabriel Candelaria, Inhalation Toxicology	2011	89
Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques Andrew T. Russo, Douglas W. Grosenbach, Trevor Brasel, The Journal of Infectious Diseases	2018	82
Microfabricated Engineered Particle Systems for Respiratory Drug Delivery and Other Pharmaceutical Applications Andres Garcia, Peter Mack, Stuart Williams, Journal of Drug Delivery NanoparticlesEngineeringBiomedical EngineeringParticle ReplicationNanomedicine	2012	73
Symposium Summary Jeffrey S. Tepper, Philip J. Kuehl, Stuart Cracknell, International Journal of Toxicology Lung DepositionAllergyRespiratory ToxicologyBetter UnderstandingPharmacology	2016	60
Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29 Nicholas B. Carrigy, Sasha E. Larsen, Valerie A. Reese, Antimicrobial Agents and Chemotherapy	2019	60
Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients Chet Leach, Philip J. Kuehl, Ramesh Chand, Annals of Allergy Asthma & Immunology AsthmaRespiratory DepositionLung DepositionAllergyRespiratory Toxicology	2012	58

Page 1